Feeds › Insider trades
Insider trades
Open-market buys and sells by officers, directors and 10% owners, from SEC Form 4. Usually filed within two business days.
About this data
- What it is
- When a company's officers, directors or owners of more than 10% buy or sell its stock, they must report the trade to the SEC on Form 4. This feed shows purchases and sales on the open market; stock grants, option exercises and shares withheld for tax are left out.
- Who files it
- The insider, usually through the company, within two business days of the trade.
- How current
- We collect new filings throughout the day on SEC business days.
- Worth knowing
- Sales are often routine: insiders sell to diversify, to pay taxes, or under a 10b5-1 plan set up months in advance. A purchase with their own money is less common, which is why many investors pay closer attention to it.
All of this comes from public filings.
Source and freshness · Information, not investment advice (disclaimer).
Open-market trades per day, last 30 days
Purchases Sales
By trade date. Insiders have two business days to file, so the most recent days fill in later.
Latest open-market insider trades
Showing: ticker NEO
| Traded | Insider | Company | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Aug 4, 2026 | Greg D. Aunan Chief Accounting Officer | NEO NeoGenomics, Inc. | Sale | 20,000 | $16.07 | $321.4K Sale | Form 4 ↗ |
| Jun 15, 2026 | Lynn A. Tetrault Director | NEO NeoGenomics, Inc. | Sale | 5,307 | $11.10 | $58.9K Sale | Form 4 ↗ |
| Jun 9, 2026 | Lynn A. Tetrault Director | NEO NeoGenomics, Inc. | Sale | 5,307 | $11.29 | $59.9K Sale | Form 4 ↗ |
| Jan 20, 2026 | Warren Stone Pres & Chief Operating Officer | NEO NeoGenomics, Inc. | Sale | 22,128 | $12.50 | $276.6K Sale | Form 4 ↗ |
| Nov 25, 2025 | Alicia C. Olivo EVP, GC & Business Development | NEO NeoGenomics, Inc. | Sale | 20,916 | $12.00 | $251.0K Sale | Form 4 ↗ |
| Oct 16, 2025 | Alicia C. Olivo EVP, GC & Business Development | NEO NeoGenomics, Inc. | Sale | 4,918 | $10.00 | $49.2K Sale | Form 4 ↗ |
| Aug 6, 2025 | Jeffrey Scott Sherman Chief Financial Officer | NEO NeoGenomics, Inc. | Buy | 20,000 | $5.62 | $112.4K Buy | Form 4 ↗ |
| Aug 6, 2025 | Anthony P. Zook Chief Executive Officer, Director | NEO NeoGenomics, Inc. | Buy | 17,900 | $5.58 | $99.9K Buy | Form 4 ↗ |
| May 27, 2025 | Michael Aaron Kelly Director | NEO NeoGenomics, Inc. | Buy | 5,000 | $7.60 | $38.0K Buy | Form 4 ↗ |
| May 12, 2025 | Warren Stone Pres & Chief Operating Officer | NEO NeoGenomics, Inc. | Buy | 5,700 | $8.58 | $48.9K Buy | Form 4 ↗ |
| May 9, 2025 | Lynn A. Tetrault Director | NEO NeoGenomics, Inc. | Buy | 7,000 | $8.14 | $57.0K Buy | Form 4 ↗ |
| May 7, 2025 | Stephen M. Kanovsky Director | NEO NeoGenomics, Inc. | Buy | 4,000 | $7.78 | $31.1K Buy | Form 4 ↗ |
| May 6, 2025 | Anthony P. Zook Chief Executive Officer, Director | NEO NeoGenomics, Inc. | Buy | 18,900 | $7.88 | $148.9K Buy | Form 4 ↗ |
| May 5, 2025 | David Brian Perez Director | NEO NeoGenomics, Inc. | Buy | 10,000 | $7.63 | $76.3K Buy | Form 4 ↗ |
| May 5, 2025 | Neil Gunn Director | NEO NeoGenomics, Inc. | Buy | 4,510 | $7.76 | $35.0K Buy | Form 4 ↗ |
| May 2, 2025 | Jeffrey Scott Sherman Chief Financial Officer | NEO NeoGenomics, Inc. | Buy | 20,000 | $7.51 | $150.2K Buy | Form 4 ↗ |
| Nov 15, 2024 | Alicia C. Olivo General Counsel | NEO NeoGenomics, Inc. | Sale | 5,175 | $15.36 | $79.5K Sale | Form 4 ↗ |
17 items, most recent first (up to 50). Every row links to its original filing. Updated Nov 15, 2026, 5:46 PM EST.
Download CSV The rows of this feed, with the filters above. A download holds at most 10,000 rows; narrow the filters to get a smaller slice.
Other feeds: Congressional trades · Executive-branch trades · Bills in Congress · Roll-call votes · Corporate PAC donations · Lobbying · Capitol Hires · Lobbying and contracts · Government contracts · Planned insider sales · Executive pay · Ownership stakes (13D / 13G) · Institutional holdings (13F) · Short interest · Fails to deliver · Daily short volume · Wikipedia page views · App store ratings · H-1B visa applications · Stock splits · 8-K events · IPO filings · Deals · Private placements (Form D) · Merger clearances (HSR) · Layoff notices (WARN) · SEC enforcement · Patents · Clinical trial updates · FDA approvals and clearances